Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04522674 · ClinicalTrials.gov registry record · Early Phase 1
Platelet-Rich Plasma (PRP) for Treatment of Symptomatic Lumbar Facet Syndrome of the Spine
A Early Phase 1 study, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 5
- Enrollment target
NCT04522674 is a Early Phase 1 study that has completed, run by University of Colorado, Denver. The registered enrollment target is 5 participants.
The verdict
NCT04522674, a Early Phase 1 study, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate the feasibility of standardized autologous platelet rich plasma injections into osteoarthritic lumbar facet joints to treat back pain and improve patient function.
Interventions
- BIOLOGICAL Autologous platelet rich plasma
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2021-02-19 |
| Est. Completion | 2022-04-28 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04522674
The ClinicalTrials.gov registry entry for NCT04522674 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Autologous platelet rich plasma is the first listed.
NCT04522674 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04522674 about?
NCT04522674 is a clinical study titled "Platelet-Rich Plasma (PRP) for Treatment of Symptomatic Lumbar Facet Syndrome of the Spine". The purpose of this study is to investigate the feasibility of standardized autologous platelet rich plasma injections into osteoarthritic lumbar facet joints to treat back pain and improve patient function.
What is the current status of trial NCT04522674?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 5 participants. The study started on 2021-02-19. Estimated completion is 2022-04-28.
What interventions are being tested in trial NCT04522674?
The interventions under investigation include: Autologous platelet rich plasma (BIOLOGICAL).
Who is sponsoring clinical trial NCT04522674?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.